Skip to content

Search for:

New to Type 1 Diabetes

Living with Diabetes

Conferences & Community

News

About CWD

New to Type 1 Diabetes
Living with Diabetes
Conferences & Community
CWD Answers
News
About CWD
Donate to CWD
Search for:

Archives

Research News

advertisement

July 15, 2009

Effect of Ingested Interferon-alpha on beta-Cell Function in Children With New-Onset Type 1 Diabetes.
Remission of type 1 diabetes following anti-CD3 antibody treatment and transplantation of embryonic pancreatic precursors.
Preservation of Beta Cell Function in Autoantibody Positive Youth with Diabetes.
Seasonal variation of diagnosis of Type 1 diabetes mellitus in children worldwide.
Maternal Body Mass Index before pregnancy, maternal weight gain during pregnancy, and risk of persistent positivity for multiple diabetes associated autoantibodies in children with the high-risk HLA genotype: The MIDIA study.
Glucagon-Like Peptide-1 Functionalized PEG Hydrogels Promote Survival and Function of Encapsulated Pancreatic beta-Cells.
Functional Brain Connectivity and Neurocognitive Functioning in Patients with Longstanding Type 1 Diabetes Mellitus with and without Microvascular Complications: a Magnetoencephalography Study.
Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes.
Study Links Nitrosamines to Mortality in Diabetes, Other Diseases.

July 1, 2009

Seeding of pancreatic islets into pre-vascularized tissue-engineering chambers.
Inflammation in Diabetic Encephalopathy is Prevented by C-Peptide.

June 24, 2009

Australia’s national trends in the incidence of Type 1 diabetes in 0-14-year-olds, 2000-2006.
Incident Dysglycemia and the Progression to Type 1 Diabetes among Participants in the Diabetes Prevention Trial-Type 1.
The effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes.
Safety and Viability of Microencapsulated Human Islets Transplanted Into Diabetic Humans.
Familial association between type 1 diabetes and other autoimmune and related diseases.
The -174GG interleukin-6 genotype is protective from retinopathy and nephropathy in juvenile onset type 1 diabetes mellitus.

June 17, 2009

The Onset of Diabetes in Three out of Four Sisters: A Japanese Family with Type 1 Diabetes. A Case Report. Free full text available in PDF format.
Pioglitazone might prevent the progression of slowly progressive type 1 diabetes. Free full text available in PDF format.

June 10, 2009

Can childhood viral infection protect from type 1 diabetes?
Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA).
Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes.
ADA: Fluorescent Intravascular Glucose Sensor Appears Accurate.
Genes play role in glycemic control in type 1 diabetes.

June 3, 2009

Interplay between PTPN22 C1858T polymorphism and cow’s milk formula exposure in type 1 diabetes.
Incident Dysglycemia and the Progression to Type 1 Diabetes among Participants in the Diabetes Prevention Trial-Type 1.
Incidence trends for childhood type 1 diabetes in Europe during 1989�2003 and predicted new cases 2005�20: a multicentre prospective registration study. See also Type 1 Diabetes Incidence Jumps 4% Annually in Europe’s Youngest.
Incidence and Time Trend of Type 1 and Type 2 Diabetes in Austrian Children 1999-2007.
Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth Study.
Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria.
Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. Free full text available in HTML and PDF formats.
Changes in autoreactive T cell avidity during type 1 diabetes development.
Lifetime prevalence of comorbid mood disorders in a representative sample of Canadians with type 1 diabetes.
Accelerated Pharmacokinetics and Glucodynamics of Prandial Insulins Injected With Recombinant Human Hyaluronidase. See also Phase 1 Study For Halozyme’s Insulin-PH20 Published, Highlights Findings For Faster Acting Insulin Formulations.
Regeneration of the Pancreas in Adult Zebrafish.
Predictors of Study Completion and Withdrawal in a Randomized Clinical Trial of a Pediatric Diabetes Adherence Intervention.
Influence of Early Nutritional Components on the Development of Murine Autoimmune Diabetes.

May 27, 2009

Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon. Free full text available in HTML and PDF formats.
Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles.
A Case-Sibling Assessment of the Association Between Skin Pigmentation and Other Vitamin D-related Factors and Type 1 Diabetes Mellitus.
Adiposity and mortality in type 1 diabetes.
Camel milk as an adjuvant therapy for the treatment of type 1 diabetes: verification of a traditional ethnomedical practice.

May 20, 2009

Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years.
How close are we to developing an alternative to human islet cell transplantation?
In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes.
Pulsatile intravenous insulin therapy: The best practice to reverse diabetes complications?
Pulse pressure and cardiovascular autonomic neuropathy according to duration of type 1 diabetes.

May 13, 2009

Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes. A randomized controlled trial.
Pig-to-nonhuman primate islet xenotransplantation.

May 6, 2009

GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes. Free full text available in PDF format.
New prospects for immunotherapy at diagnosis of type 1 diabetes.
Elevated Triglycerides Correlate with Progression of Diabetic Neuropathy.
Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes – an inception cohort study.
Epidemiology and clinical characteristics of thyroid dysfunction in children and adolescents with type 1 diabetes.
Staphylococcus aureus nasal carriage might be associated with vitamin D receptor polymorphisms in type 1 diabetes.

« Previous
1
…
69
70
71
72
73
…
94
Next »

advertisement

Last Updated: Wednesday, June 18, 2025 16:00:30 UTC

This internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

Terms of Use

About Us

Contact Us
- Contact Us
- Submit a Question

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes, EIN #46-3704802), a 501c3 not-for-profit organization, which is responsible for its contents. By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.

Children with Diabetes.com © 1995-2025 | Comments and Feedback | All Rights Reserved.

Social

Four-Star Rating Badge - Full Color

DK Popup

This is a popup.

Submit Your Story

If you’d like your story to be considered for inclusion on our website, please fill out the form below.

Name*
First Last
Email*
Enter Email Confirm Email
Address
State / Province / Region Country

Please let us know about where you live.
Date of Birth*
Month
Day
Year
We ask for your birth date so that we can limit what is used on the website if you are under 18.
Date Diagnosed
Month
Day
Year
If you don't know the exact day, don't worry. Just choose the correct month and/or correct year and note this in your story.
Your Story*
Please tell us about yourself and your connection to diabetes.
Your Photo
Accepted file types: jpg, jpeg, png, Max. file size: 25 MB.
If you have a photo, upload it here.
Short Bio
Please include a short bio of yourself so we can consider it for inclusion with the story. This will appear underneath your photo.
Consent to Use My Story and Photo*
I agree with terms below.
By submitting my information, photo, and/or video, I give Children with Diabetes permission to use my story, imagery, photograph(s), and/or video(s), in its promotional materials and publicity efforts. I understand that the imagery may be used in, but not limited to, a publication, print ad, direct-mail piece, electronic media, or other form or promotion; and that my name and additional information collected by the organization may be used in conjunction with the image(s). I release Children with Diabetes from liability for any violation of any personal or proprietary right I may have in connection with such use.

Contact Us

Help Us Understand You Better.

Please answer a few questions to help us understand how best to serve you. You are not required to answer, but we hope you will. This information will be collated and may be published on our website periodically, or may be used for publication, but we will use composite data only. We do not maintain any individual data from these items. If you ask another question at a later time, please fill this out each time.

This form is just for questions related to diabetes care. If you have questions about anything else related to Children with Diabetes, please use our Contact Us form.
This question is on behalf of:
The question applies to this age group:
This question relates to:
We've had diabetes for:
We use this treatment for diabetes:
We have the following insurance:
We receive diabetes care from:
I'm asking this question because:
Type in Your Question Here.
What is your email address?
If you would like to have the answer emailed to you, please include your email address.
Where do you live?
Please tell us where you live (city, state, and country). This information can help us answer your question.
What is your question?*
To preserve confidentiality, we strongly recommend that you do not include in your question any information that identifies you, your child, or any other individual. Please note: questions that are published may be edited for space and clarity.
Name
This field is for validation purposes and should be left unchanged.

First Name*
Last Name*
Email*
What is your connection to type 1 diabetes?*
- I have type 1 diabetes
- I have a child with type 1 diabetes
- I have type 1 and have a child with type 1
- I am a health care professional
- Other
Name
This field is for validation purposes and should be left unchanged.